UNSPSC 85752825: Revision of autologous tissue substitute in scrotum and tunica vaginalis, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in scrotum and tunica vaginalis, via natural or artificial opening endoscopic. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0VW887Z

UNSPSC 85752825 Revision of autologous tissue substitute in scrotum and tunica vaginalis, via natural or artificial opening endoscopic, a Commodity code, shows no relevant recent state and local procurement activity. The six most recent opportunities posted under or near this code span independent medical evaluation services, pharmacy benefit management, occupational medical surveillance, surgical procedure carve-out networks, temporary health professional staffing, and youth detention medical services—none of which involve urological tissue revision procedures or specialized surgical instrumentation aligned with the code's nominal scope. The apparent misalignment between the code's clinical specificity and the work actually being solicited suggests this Commodity code does not reflect current purchasing patterns in state and local government markets and warrants verification against active procurement databases before pursuit decisions are made.

The issuing bodies in the recent opportunities block include a state department (Washington State Department of Transportation), county government entities (Harris County, Collier County, Santa Clara County), a city (Phoenix, Long Beach), and regional health systems, with notices spanning RFP and RFI formats. Geographic activity centers on Arizona, California, Florida, and Washington, with no concentration in a single state or jurisdiction type. None of the recent solicitations—which closed or are closing between September 25 and October 16, 2026—relate to surgical tissue substitute procurement or the specialized urology procedures the code describes.